PAVmed (PAVM) Net Margin (2021 - 2025)
PAVmed's (PAVM) quarterly Net Margin came in at 2293.83% in Q4 2025, down 1575383.0% year-on-year from N/an in Q4 2024, and up 98.19% quarter-over-quarter from 126560.0% in Q3 2025.
PAVmed (PAVM) Net Margin (2021 - 2025) Analysis & Trends
PAVmed's Net Margin history runs 5 years deep, the most recent figure standing at 2293.83% for Q4 2025.
- On a quarterly basis, Net Margin fell 1575383.0% year-over-year to 2293.83% in Q4 2025; TTM through Dec 2025 was 3799.0%, a 273765.0% decrease from a year earlier, with the FY2025 full-year figure at 3800.0%, down 486731.0% from the prior year.
- Net Margin advanced to 2293.83% in Q4 2025 per PAVM's latest filing, from 126560.0% in the prior quarter.
- Across five years, Net Margin topped out at 221187.5% in Q1 2025 and bottomed at 221800.0% in Q2 2025.
- The 5-year median for Net Margin is 4899.33% (2021), against an average of 13103.1%.
- Biggest YoY gain for Net Margin was 22344374 bps in 2025; the steepest drop was 22068580 bps in 2025.
- Year by year, Net Margin stood at 5761.67% in 2021, then sank by 218 bps to 18332.14% in 2022, then soared by 92 bps to 1516.21% in 2023, then soared by 988 bps to 13460.0% in 2024, then tumbled by 117 bps to 2293.83% in 2025.
- Per Business Quant, the three latest PAVM Net Margin figures stand at 2293.83% (Q4 2025), 126560.0% (Q3 2025), and 221800.0% (Q2 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 9.65% |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 12.38% |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 12.84% |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 25.77% |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | - |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 16.74% |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 3.87% |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 8.01% |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | PAVmed | 9.85 Mn | -3.35 Mn | -4,000.00 | -2,293.83% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -2,293.83% |
| Sep 30, 2025 | -126,560.00% |
| Jun 30, 2025 | -221,800.00% |
| Mar 31, 2025 | 221,187.50% |
| Dec 31, 2024 | 13,460.00% |
| Jun 30, 2024 | -1,114.20% |
| Mar 31, 2024 | -2,256.24% |
| Dec 31, 2023 | -1,516.21% |
| Sep 30, 2023 | -2,243.74% |
| Jun 30, 2023 | -8,802.41% |
| Mar 31, 2023 | -4,037.00% |
| Dec 31, 2022 | -18,332.14% |
| Sep 30, 2022 | -34,469.74% |
| Mar 31, 2022 | -8,962.96% |
| Dec 31, 2021 | -5,761.67% |
| Sep 30, 2021 | -6,147.00% |